Confirms FY guidance (Il Sole 24 Ore Radiocor) - Zurich, 24 Apr - The Swiss pharmaceutical group Roche said that in the first quarter sales fell 6% to 14.399 billion francs. At constant exchange rates, the top line rose 2%.

For 2024, Roche expects an increase in sales at a mid-single digit rate at constant exchange rates. Core earnings per share are targeted to "develop broadly in line with sales growth" at constant exchange rates, excluding the impact from the resolution of tax disputes in 2023. Roche expects to further increase its dividend in Swiss francs.

AAA-Web

(RADIOCOR) 24-04-24 08:00:23 (0083) 5 NNNN